-
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
(PAR-23-284)
National Cancer Institute
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Multiple dates, see announcement.
-
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed)
(PAR-23-296)
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
Application Receipt Date(s): September 7, 2026
-
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed)
(PAR-23-297)
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
Application Receipt Date(s): September 7, 2026
-
Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional)
(PAR-23-305)
National Institute of Mental Health
Application Receipt Date(s): November 1, 2023
-
Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional)
(PAR-23-307)
National Institute of Mental Health
Application Receipt Date(s): November 1, 2023
-
NIDA REI: Training a Diverse Data Science Workforce for Addiction Research (R25 Clinical Trial Not Allowed)
(RFA-DA-24-025)
National Institute on Drug Abuse
Application Receipt Date(s): January 24, 2024
-
NIDA REI: Academic Research Enhancement Award (AREA) Training a Diverse Data Science Workforce for Addiction Research (R15 Clinical Trial Not Allowed)
(RFA-DA-24-026)
National Institute on Drug Abuse
Application Receipt Date(s): January 24, 2024
-
HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional)
(RFA-DA-24-066)
National Institute on Drug Abuse
National Institute on Aging
National Center for Complementary and Integrative Health
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Application Receipt Date(s): Multiple dates, see announcement.
-
HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R01 Clinical Trial Optional)
(RFA-DA-24-067)
National Institute on Drug Abuse
National Institute on Aging
National Center for Complementary and Integrative Health
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Application Receipt Date(s): Multiple dates, see announcement.
-
Single Source: Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed)
(RFA-DA-25-015)
National Institute on Drug Abuse
Application Receipt Date(s): August 13, 2024
-
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R01 Clinical Trial Not Allowed)
(RFA-DA-25-016)
National Institute on Drug Abuse
Application Receipt Date(s): August 13, 2024
-
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R21 Clinical Trial Not Allowed)
(RFA-DA-25-017)
National Institute on Drug Abuse
Application Receipt Date(s): August 13, 2024
-
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
(RFA-EY-23-001)
National Eye Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): June 15, 2026
-
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R01 Clinical Trial Optional)
(RFA-MH-24-330)
National Institute of Mental Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women's Health
Office of AIDS Research
Application Receipt Date(s): November 22, 2023
-
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R21 Clinical Trial Optional)
(RFA-MH-24-331)
National Institute of Mental Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women's Health
Office of AIDS Research
Application Receipt Date(s): November 22, 2023
-
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional)
(RFA-MH-24-332)
National Institute of Mental Health
Office of Research on Women's Health
Office of AIDS Research
Application Receipt Date(s): November 22, 2023